CLINICAL_TRIALS
trial_result
· 2013-11-27
Clinical Trial Update: A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200 [Phase 1]
Summary
Phase 1, open-label safety and pharmacokinetic study of EDI200 in X-linked hypohidrotic ectodermal dysplasia completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Edimer Pharmaceuticals | Conditions: X-linked Hypohidrotic Ectodermal Dysplasia | Phase 1 | Status: COMPLETED